Analyst Reco. MorphoSys AG

Equities

Market Closed - Xetra Other stock markets 11:35:21 2024-06-12 am EDT			5-day change	1st Jan Change
68 ^EUR	0.00%		-0.29%	+100.00%

Jun. 10	MorphoSys AG(XTRA:MOR) dropped from S&P Global BMI Index	CI
Jun. 06	MorphoSys AG Announces Board Changes	CI

MORPHOSYS : UBS reiterates its Neutral rating	May. 06	ZD
MORPHOSYS : UBS remains Neutral	Apr. 30	ZD
Trending : Novartis Begins Tender Offer for MorphoSys Shares	Apr. 11	DJ
MORPHOSYS : UBS sticks Neutral	Feb. 16	ZD
Novartis' Midterm Sales Growth Prospects Limited as Patent Expirations Loom, Berenberg Says	Feb. 14	MT
MORPHOSYS : UBS revises his opinion and turns to Neutral	Feb. 07	ZD
MORPHOSYS : UBS remains its Buy rating	Feb. 07	ZD
Swiss Market Index Blinks Red Amid Renewed Rate Jitters	Feb. 06	MT
North American Morning Briefing : Rate Doubts Keep Pressure on Stocks; More Earnings in Focus	Feb. 06	DJ
MORPHOSYS : UBS reiterates its Buy rating	Feb. 06	ZD
European Midday Briefing : Stocks Higher But Gains Capped On Rate Doubts	Feb. 06	DJ
MORPHOSYS : JP Morgan reaffirms its Buy rating	Feb. 05	ZD
MORPHOSYS : UBS reiterates its Buy rating	Feb. 05	ZD
MORPHOSYS : Deutsche Bank sticks Neutral	Jan. 31	ZD
MORPHOSYS : JP Morgan gives a Buy rating	Jan. 30	ZD
UBS reiterates Morphosys at 'Buy' - Target 47 euros	Jan. 30	DP
MORPHOSYS : UBS remains its Buy rating	Jan. 30	ZD
MORPHOSYS : UBS reiterates its Buy rating	Jan. 29	ZD
Lower Bank Earnings, Higher Interest Rates Weigh on Exchange-Traded Funds, Equity Futures Pre-Bell Tuesday	Jan. 16	MT
MORPHOSYS : JP Morgan reiterates its Buy rating	Jan. 15	ZD

No results for this search